nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—KCNE1—renal system—muscle cancer	0.0232	0.102	CbGeAlD
Indapamide—KCNE1—head—muscle cancer	0.0155	0.0683	CbGeAlD
Indapamide—KCNE1—testis—muscle cancer	0.015	0.066	CbGeAlD
Indapamide—CA7—renal system—muscle cancer	0.0117	0.0515	CbGeAlD
Indapamide—SLC12A3—renal system—muscle cancer	0.0115	0.0504	CbGeAlD
Indapamide—KCNQ1—renal system—muscle cancer	0.0107	0.0469	CbGeAlD
Indapamide—KCNQ1—cardiac atrium—muscle cancer	0.00954	0.042	CbGeAlD
Indapamide—KCNQ1—bone marrow—muscle cancer	0.00805	0.0355	CbGeAlD
Indapamide—CA9—tendon—muscle cancer	0.00802	0.0353	CbGeAlD
Indapamide—CA12—renal system—muscle cancer	0.0076	0.0334	CbGeAlD
Indapamide—KCNQ1—head—muscle cancer	0.00713	0.0314	CbGeAlD
Indapamide—KCNQ1—testis—muscle cancer	0.00689	0.0303	CbGeAlD
Indapamide—CA9—testis—muscle cancer	0.00664	0.0292	CbGeAlD
Indapamide—CA5B—cardiac atrium—muscle cancer	0.0061	0.0269	CbGeAlD
Indapamide—CA5B—tendon—muscle cancer	0.00532	0.0234	CbGeAlD
Indapamide—CA2—embryo—muscle cancer	0.00515	0.0227	CbGeAlD
Indapamide—CA12—head—muscle cancer	0.00508	0.0224	CbGeAlD
Indapamide—CA5B—vagina—muscle cancer	0.00494	0.0217	CbGeAlD
Indapamide—CA4—renal system—muscle cancer	0.0047	0.0207	CbGeAlD
Indapamide—CA5B—head—muscle cancer	0.00456	0.0201	CbGeAlD
Indapamide—CA5B—testis—muscle cancer	0.00441	0.0194	CbGeAlD
Indapamide—CA4—cardiac atrium—muscle cancer	0.00421	0.0185	CbGeAlD
Indapamide—CA2—smooth muscle tissue—muscle cancer	0.00405	0.0178	CbGeAlD
Indapamide—CA2—renal system—muscle cancer	0.0039	0.0172	CbGeAlD
Indapamide—CA4—tendon—muscle cancer	0.00367	0.0162	CbGeAlD
Indapamide—CA4—bone marrow—muscle cancer	0.00356	0.0157	CbGeAlD
Indapamide—CA2—cardiac atrium—muscle cancer	0.00349	0.0154	CbGeAlD
Indapamide—CA4—head—muscle cancer	0.00315	0.0139	CbGeAlD
Indapamide—CA2—tendon—muscle cancer	0.00305	0.0134	CbGeAlD
Indapamide—CA4—testis—muscle cancer	0.00304	0.0134	CbGeAlD
Indapamide—CA2—bone marrow—muscle cancer	0.00295	0.013	CbGeAlD
Indapamide—CA2—vagina—muscle cancer	0.00283	0.0124	CbGeAlD
Indapamide—CA2—head—muscle cancer	0.00261	0.0115	CbGeAlD
Indapamide—CA2—testis—muscle cancer	0.00252	0.0111	CbGeAlD
Indapamide—CYP3A4—renal system—muscle cancer	0.00252	0.0111	CbGeAlD
Indapamide—Leukopenia—Etoposide—muscle cancer	0.00147	0.00191	CcSEcCtD
Indapamide—Purpura—Doxorubicin—muscle cancer	0.00147	0.0019	CcSEcCtD
Indapamide—Abdominal pain—Dactinomycin—muscle cancer	0.00147	0.0019	CcSEcCtD
Indapamide—Body temperature increased—Dactinomycin—muscle cancer	0.00147	0.0019	CcSEcCtD
Indapamide—Loss of consciousness—Etoposide—muscle cancer	0.00145	0.00187	CcSEcCtD
Indapamide—Lethargy—Doxorubicin—muscle cancer	0.00145	0.00187	CcSEcCtD
Indapamide—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00145	0.00187	CcSEcCtD
Indapamide—Decreased appetite—Vincristine—muscle cancer	0.00144	0.00187	CcSEcCtD
Indapamide—Cough—Etoposide—muscle cancer	0.00144	0.00186	CcSEcCtD
Indapamide—Gastrointestinal disorder—Vincristine—muscle cancer	0.00143	0.00185	CcSEcCtD
Indapamide—Fatigue—Vincristine—muscle cancer	0.00143	0.00185	CcSEcCtD
Indapamide—Hyponatraemia—Doxorubicin—muscle cancer	0.00142	0.00184	CcSEcCtD
Indapamide—Constipation—Vincristine—muscle cancer	0.00142	0.00184	CcSEcCtD
Indapamide—Pain—Vincristine—muscle cancer	0.00142	0.00184	CcSEcCtD
Indapamide—Osteoarthritis—Doxorubicin—muscle cancer	0.00142	0.00184	CcSEcCtD
Indapamide—Asthma—Methotrexate—muscle cancer	0.00141	0.00183	CcSEcCtD
Indapamide—Chest pain—Etoposide—muscle cancer	0.0014	0.00181	CcSEcCtD
Indapamide—Migraine—Doxorubicin—muscle cancer	0.00139	0.00181	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00139	0.0018	CcSEcCtD
Indapamide—Pancreatitis—Methotrexate—muscle cancer	0.00139	0.0018	CcSEcCtD
Indapamide—Discomfort—Etoposide—muscle cancer	0.00138	0.00179	CcSEcCtD
Indapamide—Face oedema—Doxorubicin—muscle cancer	0.00137	0.00177	CcSEcCtD
Indapamide—Hypersensitivity—Dactinomycin—muscle cancer	0.00137	0.00177	CcSEcCtD
Indapamide—Gastrointestinal pain—Vincristine—muscle cancer	0.00136	0.00176	CcSEcCtD
Indapamide—Anaphylactic shock—Etoposide—muscle cancer	0.00134	0.00174	CcSEcCtD
Indapamide—Infection—Etoposide—muscle cancer	0.00133	0.00173	CcSEcCtD
Indapamide—Ataxia—Doxorubicin—muscle cancer	0.00133	0.00173	CcSEcCtD
Indapamide—Asthenia—Dactinomycin—muscle cancer	0.00133	0.00172	CcSEcCtD
Indapamide—Dysuria—Methotrexate—muscle cancer	0.00132	0.00171	CcSEcCtD
Indapamide—Dehydration—Doxorubicin—muscle cancer	0.00132	0.00171	CcSEcCtD
Indapamide—Thrombocytopenia—Etoposide—muscle cancer	0.00131	0.0017	CcSEcCtD
Indapamide—Tachycardia—Etoposide—muscle cancer	0.00131	0.0017	CcSEcCtD
Indapamide—Body temperature increased—Vincristine—muscle cancer	0.00131	0.0017	CcSEcCtD
Indapamide—Abdominal pain—Vincristine—muscle cancer	0.00131	0.0017	CcSEcCtD
Indapamide—Liver function test abnormal—Doxorubicin—muscle cancer	0.00131	0.0017	CcSEcCtD
Indapamide—Skin disorder—Etoposide—muscle cancer	0.0013	0.00169	CcSEcCtD
Indapamide—Erectile dysfunction—Methotrexate—muscle cancer	0.0013	0.00169	CcSEcCtD
Indapamide—Hyperhidrosis—Etoposide—muscle cancer	0.0013	0.00168	CcSEcCtD
Indapamide—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00129	0.00168	CcSEcCtD
Indapamide—Abdominal pain upper—Doxorubicin—muscle cancer	0.00129	0.00168	CcSEcCtD
Indapamide—Photosensitivity reaction—Methotrexate—muscle cancer	0.00129	0.00167	CcSEcCtD
Indapamide—Hypokalaemia—Doxorubicin—muscle cancer	0.00129	0.00167	CcSEcCtD
Indapamide—Anorexia—Etoposide—muscle cancer	0.00128	0.00166	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00128	0.00165	CcSEcCtD
Indapamide—Diarrhoea—Dactinomycin—muscle cancer	0.00127	0.00164	CcSEcCtD
Indapamide—Pneumonia—Methotrexate—muscle cancer	0.00127	0.00164	CcSEcCtD
Indapamide—Nasopharyngitis—Doxorubicin—muscle cancer	0.00127	0.00164	CcSEcCtD
Indapamide—Drowsiness—Methotrexate—muscle cancer	0.00126	0.00163	CcSEcCtD
Indapamide—Depression—Methotrexate—muscle cancer	0.00126	0.00163	CcSEcCtD
Indapamide—Hypotension—Etoposide—muscle cancer	0.00125	0.00163	CcSEcCtD
Indapamide—Gastritis—Doxorubicin—muscle cancer	0.00125	0.00162	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00125	0.00162	CcSEcCtD
Indapamide—Muscular weakness—Doxorubicin—muscle cancer	0.00125	0.00162	CcSEcCtD
Indapamide—Renal failure—Methotrexate—muscle cancer	0.00124	0.00161	CcSEcCtD
Indapamide—Stomatitis—Methotrexate—muscle cancer	0.00123	0.00159	CcSEcCtD
Indapamide—Conjunctivitis—Methotrexate—muscle cancer	0.00123	0.00159	CcSEcCtD
Indapamide—Influenza—Doxorubicin—muscle cancer	0.00122	0.00159	CcSEcCtD
Indapamide—Asthma—Doxorubicin—muscle cancer	0.00122	0.00159	CcSEcCtD
Indapamide—Dysphagia—Doxorubicin—muscle cancer	0.00122	0.00159	CcSEcCtD
Indapamide—Hypersensitivity—Vincristine—muscle cancer	0.00122	0.00158	CcSEcCtD
Indapamide—Sweating—Methotrexate—muscle cancer	0.00121	0.00157	CcSEcCtD
Indapamide—Paraesthesia—Etoposide—muscle cancer	0.00121	0.00156	CcSEcCtD
Indapamide—Pancreatitis—Doxorubicin—muscle cancer	0.0012	0.00156	CcSEcCtD
Indapamide—Dyspnoea—Etoposide—muscle cancer	0.0012	0.00155	CcSEcCtD
Indapamide—Somnolence—Etoposide—muscle cancer	0.00119	0.00155	CcSEcCtD
Indapamide—Angina pectoris—Doxorubicin—muscle cancer	0.00119	0.00155	CcSEcCtD
Indapamide—Hepatobiliary disease—Methotrexate—muscle cancer	0.00119	0.00155	CcSEcCtD
Indapamide—Asthenia—Vincristine—muscle cancer	0.00119	0.00154	CcSEcCtD
Indapamide—Vomiting—Dactinomycin—muscle cancer	0.00118	0.00153	CcSEcCtD
Indapamide—Bronchitis—Doxorubicin—muscle cancer	0.00118	0.00153	CcSEcCtD
Indapamide—Agranulocytosis—Methotrexate—muscle cancer	0.00118	0.00152	CcSEcCtD
Indapamide—Rash—Dactinomycin—muscle cancer	0.00117	0.00152	CcSEcCtD
Indapamide—Decreased appetite—Etoposide—muscle cancer	0.00117	0.00151	CcSEcCtD
Indapamide—Bumetanide—PTGS2—muscle cancer	0.00117	1	CrCbGaD
Indapamide—Gastrointestinal disorder—Etoposide—muscle cancer	0.00116	0.0015	CcSEcCtD
Indapamide—Fatigue—Etoposide—muscle cancer	0.00116	0.0015	CcSEcCtD
Indapamide—Pain—Etoposide—muscle cancer	0.00115	0.00149	CcSEcCtD
Indapamide—Constipation—Etoposide—muscle cancer	0.00115	0.00149	CcSEcCtD
Indapamide—Dysuria—Doxorubicin—muscle cancer	0.00115	0.00148	CcSEcCtD
Indapamide—Diarrhoea—Vincristine—muscle cancer	0.00113	0.00147	CcSEcCtD
Indapamide—Hepatitis—Methotrexate—muscle cancer	0.00113	0.00147	CcSEcCtD
Indapamide—Pollakiuria—Doxorubicin—muscle cancer	0.00113	0.00147	CcSEcCtD
Indapamide—Pharyngitis—Methotrexate—muscle cancer	0.00112	0.00146	CcSEcCtD
Indapamide—Urinary tract disorder—Methotrexate—muscle cancer	0.00112	0.00145	CcSEcCtD
Indapamide—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00112	0.00145	CcSEcCtD
Indapamide—Urethral disorder—Methotrexate—muscle cancer	0.00111	0.00144	CcSEcCtD
Indapamide—Weight decreased—Doxorubicin—muscle cancer	0.00111	0.00144	CcSEcCtD
Indapamide—Feeling abnormal—Etoposide—muscle cancer	0.00111	0.00143	CcSEcCtD
Indapamide—Hyperglycaemia—Doxorubicin—muscle cancer	0.0011	0.00143	CcSEcCtD
Indapamide—Nausea—Dactinomycin—muscle cancer	0.0011	0.00143	CcSEcCtD
Indapamide—Pneumonia—Doxorubicin—muscle cancer	0.0011	0.00142	CcSEcCtD
Indapamide—Gastrointestinal pain—Etoposide—muscle cancer	0.0011	0.00142	CcSEcCtD
Indapamide—Dizziness—Vincristine—muscle cancer	0.0011	0.00142	CcSEcCtD
Indapamide—Drowsiness—Doxorubicin—muscle cancer	0.00109	0.00141	CcSEcCtD
Indapamide—Visual impairment—Methotrexate—muscle cancer	0.00109	0.00141	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00108	0.0014	CcSEcCtD
Indapamide—Renal failure—Doxorubicin—muscle cancer	0.00107	0.00139	CcSEcCtD
Indapamide—Erythema multiforme—Methotrexate—muscle cancer	0.00107	0.00139	CcSEcCtD
Indapamide—Urticaria—Etoposide—muscle cancer	0.00107	0.00138	CcSEcCtD
Indapamide—Stomatitis—Doxorubicin—muscle cancer	0.00106	0.00138	CcSEcCtD
Indapamide—Jaundice—Doxorubicin—muscle cancer	0.00106	0.00138	CcSEcCtD
Indapamide—Abdominal pain—Etoposide—muscle cancer	0.00106	0.00138	CcSEcCtD
Indapamide—Body temperature increased—Etoposide—muscle cancer	0.00106	0.00138	CcSEcCtD
Indapamide—Urinary tract infection—Doxorubicin—muscle cancer	0.00106	0.00138	CcSEcCtD
Indapamide—Conjunctivitis—Doxorubicin—muscle cancer	0.00106	0.00138	CcSEcCtD
Indapamide—Tinnitus—Methotrexate—muscle cancer	0.00106	0.00137	CcSEcCtD
Indapamide—Vomiting—Vincristine—muscle cancer	0.00105	0.00137	CcSEcCtD
Indapamide—Cardiac disorder—Methotrexate—muscle cancer	0.00105	0.00136	CcSEcCtD
Indapamide—Sweating—Doxorubicin—muscle cancer	0.00105	0.00136	CcSEcCtD
Indapamide—Rash—Vincristine—muscle cancer	0.00105	0.00135	CcSEcCtD
Indapamide—Dermatitis—Vincristine—muscle cancer	0.00104	0.00135	CcSEcCtD
Indapamide—Headache—Vincristine—muscle cancer	0.00104	0.00135	CcSEcCtD
Indapamide—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00103	0.00134	CcSEcCtD
Indapamide—Sinusitis—Doxorubicin—muscle cancer	0.00102	0.00133	CcSEcCtD
Indapamide—Agranulocytosis—Doxorubicin—muscle cancer	0.00102	0.00132	CcSEcCtD
Indapamide—Hypersensitivity—Etoposide—muscle cancer	0.000989	0.00128	CcSEcCtD
Indapamide—Erythema—Methotrexate—muscle cancer	0.000985	0.00128	CcSEcCtD
Indapamide—Malnutrition—Methotrexate—muscle cancer	0.000985	0.00128	CcSEcCtD
Indapamide—Nausea—Vincristine—muscle cancer	0.000984	0.00128	CcSEcCtD
Indapamide—Rhinitis—Doxorubicin—muscle cancer	0.000983	0.00127	CcSEcCtD
Indapamide—Hepatitis—Doxorubicin—muscle cancer	0.00098	0.00127	CcSEcCtD
Indapamide—Hypoaesthesia—Doxorubicin—muscle cancer	0.000975	0.00126	CcSEcCtD
Indapamide—Pharyngitis—Doxorubicin—muscle cancer	0.000973	0.00126	CcSEcCtD
Indapamide—Urinary tract disorder—Doxorubicin—muscle cancer	0.000968	0.00125	CcSEcCtD
Indapamide—Oedema peripheral—Doxorubicin—muscle cancer	0.000966	0.00125	CcSEcCtD
Indapamide—Dysgeusia—Methotrexate—muscle cancer	0.000965	0.00125	CcSEcCtD
Indapamide—Asthenia—Etoposide—muscle cancer	0.000963	0.00125	CcSEcCtD
Indapamide—Urethral disorder—Doxorubicin—muscle cancer	0.000961	0.00125	CcSEcCtD
Indapamide—Back pain—Methotrexate—muscle cancer	0.000953	0.00124	CcSEcCtD
Indapamide—Pruritus—Etoposide—muscle cancer	0.00095	0.00123	CcSEcCtD
Indapamide—Visual impairment—Doxorubicin—muscle cancer	0.000945	0.00122	CcSEcCtD
Indapamide—Vision blurred—Methotrexate—muscle cancer	0.000929	0.0012	CcSEcCtD
Indapamide—Erythema multiforme—Doxorubicin—muscle cancer	0.000927	0.0012	CcSEcCtD
Indapamide—Diarrhoea—Etoposide—muscle cancer	0.000919	0.00119	CcSEcCtD
Indapamide—Ill-defined disorder—Methotrexate—muscle cancer	0.000914	0.00118	CcSEcCtD
Indapamide—Tinnitus—Doxorubicin—muscle cancer	0.000914	0.00118	CcSEcCtD
Indapamide—Anaemia—Methotrexate—muscle cancer	0.000911	0.00118	CcSEcCtD
Indapamide—Cardiac disorder—Doxorubicin—muscle cancer	0.00091	0.00118	CcSEcCtD
Indapamide—Flushing—Doxorubicin—muscle cancer	0.00091	0.00118	CcSEcCtD
Indapamide—Malaise—Methotrexate—muscle cancer	0.000889	0.00115	CcSEcCtD
Indapamide—Dizziness—Etoposide—muscle cancer	0.000888	0.00115	CcSEcCtD
Indapamide—Vertigo—Methotrexate—muscle cancer	0.000885	0.00115	CcSEcCtD
Indapamide—Leukopenia—Methotrexate—muscle cancer	0.000882	0.00114	CcSEcCtD
Indapamide—Arrhythmia—Doxorubicin—muscle cancer	0.000876	0.00113	CcSEcCtD
Indapamide—Cough—Methotrexate—muscle cancer	0.00086	0.00111	CcSEcCtD
Indapamide—Vomiting—Etoposide—muscle cancer	0.000854	0.00111	CcSEcCtD
Indapamide—Erythema—Doxorubicin—muscle cancer	0.000853	0.00111	CcSEcCtD
Indapamide—Malnutrition—Doxorubicin—muscle cancer	0.000853	0.00111	CcSEcCtD
Indapamide—Rash—Etoposide—muscle cancer	0.000847	0.0011	CcSEcCtD
Indapamide—Dermatitis—Etoposide—muscle cancer	0.000846	0.0011	CcSEcCtD
Indapamide—Headache—Etoposide—muscle cancer	0.000841	0.00109	CcSEcCtD
Indapamide—Flatulence—Doxorubicin—muscle cancer	0.000841	0.00109	CcSEcCtD
Indapamide—Arthralgia—Methotrexate—muscle cancer	0.000839	0.00109	CcSEcCtD
Indapamide—Chest pain—Methotrexate—muscle cancer	0.000839	0.00109	CcSEcCtD
Indapamide—Myalgia—Methotrexate—muscle cancer	0.000839	0.00109	CcSEcCtD
Indapamide—Tension—Doxorubicin—muscle cancer	0.000837	0.00109	CcSEcCtD
Indapamide—Dysgeusia—Doxorubicin—muscle cancer	0.000836	0.00108	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000833	0.00108	CcSEcCtD
Indapamide—Discomfort—Methotrexate—muscle cancer	0.000829	0.00107	CcSEcCtD
Indapamide—Nervousness—Doxorubicin—muscle cancer	0.000829	0.00107	CcSEcCtD
Indapamide—Back pain—Doxorubicin—muscle cancer	0.000825	0.00107	CcSEcCtD
Indapamide—Muscle spasms—Doxorubicin—muscle cancer	0.00082	0.00106	CcSEcCtD
Indapamide—Anaphylactic shock—Methotrexate—muscle cancer	0.000804	0.00104	CcSEcCtD
Indapamide—Vision blurred—Doxorubicin—muscle cancer	0.000804	0.00104	CcSEcCtD
Indapamide—Infection—Methotrexate—muscle cancer	0.000799	0.00104	CcSEcCtD
Indapamide—Nausea—Etoposide—muscle cancer	0.000797	0.00103	CcSEcCtD
Indapamide—Ill-defined disorder—Doxorubicin—muscle cancer	0.000792	0.00103	CcSEcCtD
Indapamide—Nervous system disorder—Methotrexate—muscle cancer	0.000789	0.00102	CcSEcCtD
Indapamide—Anaemia—Doxorubicin—muscle cancer	0.000789	0.00102	CcSEcCtD
Indapamide—Thrombocytopenia—Methotrexate—muscle cancer	0.000787	0.00102	CcSEcCtD
Indapamide—Agitation—Doxorubicin—muscle cancer	0.000784	0.00102	CcSEcCtD
Indapamide—Skin disorder—Methotrexate—muscle cancer	0.000781	0.00101	CcSEcCtD
Indapamide—Hyperhidrosis—Methotrexate—muscle cancer	0.000777	0.00101	CcSEcCtD
Indapamide—Malaise—Doxorubicin—muscle cancer	0.000769	0.000997	CcSEcCtD
Indapamide—Vertigo—Doxorubicin—muscle cancer	0.000767	0.000993	CcSEcCtD
Indapamide—Anorexia—Methotrexate—muscle cancer	0.000767	0.000993	CcSEcCtD
Indapamide—Syncope—Doxorubicin—muscle cancer	0.000765	0.000992	CcSEcCtD
Indapamide—Leukopenia—Doxorubicin—muscle cancer	0.000764	0.00099	CcSEcCtD
Indapamide—Palpitations—Doxorubicin—muscle cancer	0.000754	0.000977	CcSEcCtD
Indapamide—Hypotension—Methotrexate—muscle cancer	0.000751	0.000974	CcSEcCtD
Indapamide—Loss of consciousness—Doxorubicin—muscle cancer	0.00075	0.000972	CcSEcCtD
Indapamide—Cough—Doxorubicin—muscle cancer	0.000745	0.000965	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000733	0.00095	CcSEcCtD
Indapamide—Insomnia—Methotrexate—muscle cancer	0.000727	0.000943	CcSEcCtD
Indapamide—Myalgia—Doxorubicin—muscle cancer	0.000726	0.000941	CcSEcCtD
Indapamide—Chest pain—Doxorubicin—muscle cancer	0.000726	0.000941	CcSEcCtD
Indapamide—Arthralgia—Doxorubicin—muscle cancer	0.000726	0.000941	CcSEcCtD
Indapamide—Anxiety—Doxorubicin—muscle cancer	0.000724	0.000938	CcSEcCtD
Indapamide—Paraesthesia—Methotrexate—muscle cancer	0.000722	0.000936	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000721	0.000935	CcSEcCtD
Indapamide—Discomfort—Doxorubicin—muscle cancer	0.000718	0.00093	CcSEcCtD
Indapamide—Dyspnoea—Methotrexate—muscle cancer	0.000717	0.000929	CcSEcCtD
Indapamide—Somnolence—Methotrexate—muscle cancer	0.000715	0.000926	CcSEcCtD
Indapamide—Dry mouth—Doxorubicin—muscle cancer	0.00071	0.000921	CcSEcCtD
Indapamide—Dyspepsia—Methotrexate—muscle cancer	0.000708	0.000917	CcSEcCtD
Indapamide—Decreased appetite—Methotrexate—muscle cancer	0.000699	0.000906	CcSEcCtD
Indapamide—Anaphylactic shock—Doxorubicin—muscle cancer	0.000696	0.000902	CcSEcCtD
Indapamide—Oedema—Doxorubicin—muscle cancer	0.000696	0.000902	CcSEcCtD
Indapamide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000694	0.0009	CcSEcCtD
Indapamide—Fatigue—Methotrexate—muscle cancer	0.000693	0.000899	CcSEcCtD
Indapamide—Infection—Doxorubicin—muscle cancer	0.000692	0.000897	CcSEcCtD
Indapamide—Pain—Methotrexate—muscle cancer	0.000688	0.000891	CcSEcCtD
Indapamide—Shock—Doxorubicin—muscle cancer	0.000685	0.000888	CcSEcCtD
Indapamide—Nervous system disorder—Doxorubicin—muscle cancer	0.000683	0.000885	CcSEcCtD
Indapamide—Thrombocytopenia—Doxorubicin—muscle cancer	0.000682	0.000884	CcSEcCtD
Indapamide—Tachycardia—Doxorubicin—muscle cancer	0.00068	0.000881	CcSEcCtD
Indapamide—Skin disorder—Doxorubicin—muscle cancer	0.000676	0.000877	CcSEcCtD
Indapamide—Hyperhidrosis—Doxorubicin—muscle cancer	0.000673	0.000872	CcSEcCtD
Indapamide—Anorexia—Doxorubicin—muscle cancer	0.000664	0.00086	CcSEcCtD
Indapamide—Feeling abnormal—Methotrexate—muscle cancer	0.000663	0.000859	CcSEcCtD
Indapamide—Gastrointestinal pain—Methotrexate—muscle cancer	0.000658	0.000852	CcSEcCtD
Indapamide—Hypotension—Doxorubicin—muscle cancer	0.000651	0.000843	CcSEcCtD
Indapamide—Urticaria—Methotrexate—muscle cancer	0.000639	0.000828	CcSEcCtD
Indapamide—Abdominal pain—Methotrexate—muscle cancer	0.000636	0.000824	CcSEcCtD
Indapamide—Body temperature increased—Methotrexate—muscle cancer	0.000636	0.000824	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000634	0.000822	CcSEcCtD
Indapamide—Insomnia—Doxorubicin—muscle cancer	0.00063	0.000816	CcSEcCtD
Indapamide—Paraesthesia—Doxorubicin—muscle cancer	0.000625	0.00081	CcSEcCtD
Indapamide—Dyspnoea—Doxorubicin—muscle cancer	0.000621	0.000805	CcSEcCtD
Indapamide—Somnolence—Doxorubicin—muscle cancer	0.000619	0.000802	CcSEcCtD
Indapamide—Dyspepsia—Doxorubicin—muscle cancer	0.000613	0.000794	CcSEcCtD
Indapamide—Decreased appetite—Doxorubicin—muscle cancer	0.000605	0.000784	CcSEcCtD
Indapamide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000601	0.000779	CcSEcCtD
Indapamide—Fatigue—Doxorubicin—muscle cancer	0.0006	0.000778	CcSEcCtD
Indapamide—Pain—Doxorubicin—muscle cancer	0.000595	0.000772	CcSEcCtD
Indapamide—Constipation—Doxorubicin—muscle cancer	0.000595	0.000772	CcSEcCtD
Indapamide—Hypersensitivity—Methotrexate—muscle cancer	0.000592	0.000768	CcSEcCtD
Indapamide—Asthenia—Methotrexate—muscle cancer	0.000577	0.000748	CcSEcCtD
Indapamide—Feeling abnormal—Doxorubicin—muscle cancer	0.000574	0.000744	CcSEcCtD
Indapamide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000569	0.000738	CcSEcCtD
Indapamide—Pruritus—Methotrexate—muscle cancer	0.000569	0.000737	CcSEcCtD
Indapamide—Urticaria—Doxorubicin—muscle cancer	0.000553	0.000717	CcSEcCtD
Indapamide—Abdominal pain—Doxorubicin—muscle cancer	0.00055	0.000713	CcSEcCtD
Indapamide—Body temperature increased—Doxorubicin—muscle cancer	0.00055	0.000713	CcSEcCtD
Indapamide—Diarrhoea—Methotrexate—muscle cancer	0.00055	0.000713	CcSEcCtD
Indapamide—Dizziness—Methotrexate—muscle cancer	0.000532	0.000689	CcSEcCtD
Indapamide—Hypersensitivity—Doxorubicin—muscle cancer	0.000513	0.000665	CcSEcCtD
Indapamide—Vomiting—Methotrexate—muscle cancer	0.000511	0.000663	CcSEcCtD
Indapamide—Rash—Methotrexate—muscle cancer	0.000507	0.000657	CcSEcCtD
Indapamide—Dermatitis—Methotrexate—muscle cancer	0.000507	0.000657	CcSEcCtD
Indapamide—Headache—Methotrexate—muscle cancer	0.000504	0.000653	CcSEcCtD
Indapamide—Asthenia—Doxorubicin—muscle cancer	0.0005	0.000647	CcSEcCtD
Indapamide—Pruritus—Doxorubicin—muscle cancer	0.000493	0.000638	CcSEcCtD
Indapamide—Nausea—Methotrexate—muscle cancer	0.000478	0.000619	CcSEcCtD
Indapamide—Diarrhoea—Doxorubicin—muscle cancer	0.000476	0.000617	CcSEcCtD
Indapamide—Dizziness—Doxorubicin—muscle cancer	0.00046	0.000597	CcSEcCtD
Indapamide—Vomiting—Doxorubicin—muscle cancer	0.000443	0.000574	CcSEcCtD
Indapamide—Rash—Doxorubicin—muscle cancer	0.000439	0.000569	CcSEcCtD
Indapamide—Dermatitis—Doxorubicin—muscle cancer	0.000439	0.000568	CcSEcCtD
Indapamide—Headache—Doxorubicin—muscle cancer	0.000436	0.000565	CcSEcCtD
Indapamide—Nausea—Doxorubicin—muscle cancer	0.000414	0.000536	CcSEcCtD
